Liver transplantation in septuagenarians receiving model for end‐stage liver disease exception points for hepatocellular carcinoma: The national experience
Jason Schwartz, Heather Thiesset, Terry Box, William Hutson, John Sorensen – 23 July 2012
Jason Schwartz, Heather Thiesset, Terry Box, William Hutson, John Sorensen – 23 July 2012
Rania Rabie, Khalid Mumtaz, Eberhard L. Renner – 23 July 2012 – Cyclosporine A (CSA), but not tacrolimus (TAC), inhibits hepatitis C virus (HCV) replication in vitro. Clinical reports on the efficacy of interferon‐α (IFNα)–based antiviral therapy (AVT) for recurrent HCV after liver transplantation (LT) with CSA and TAC are conflicting. Our aim was to assess whether AVT for recurrent HCV after LT is more effective with CSA or TAC. We performed an electronic database search (1995‐2012) and a manual abstract search (2005‐2012).
Andres F. Carrion, Paul Martin – 23 July 2012 – Watch the interview with the authors
Elizabeth C. Verna, Robert S. Brown – 23 July 2012 – Watch the interview with the authors
Douglas Mogul, Kathleen B. Schwarz – 23 July 2012 – Watch an interview with Dr. Schwarz
Ranjeeta Bahirwani, K. Rajender Reddy – 23 July 2012 – Watch the interview with the authors
Elizabeth C. Verna, Robert S. Brown – 23 July 2012 – Watch the interview with the authors
David C. Mulligan – 23 July 2012
Ranjeeta Bahirwani, K. Rajender Reddy – 23 July 2012 – Watch the interview with the authors
Elizabeth C. Verna, Robert S. Brown – 23 July 2012 – Watch the interview with the authors